AFL Stock Summary and Trading Ideas (Aflac | NYSE:AFL)

Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Aflac trades on the NYSE stock market under the symbol AFL.

As of April 8, 2025, AFL stock price declined to $99.77 with 2,411,132 million shares trading.

AFL has a beta of 0.48, meaning it tends to be less sensitive to market movements. AFL has a correlation of 0.14 to the broad based SPY ETF.

AFL has a market cap of $54.53 billion. This is considered a Large Cap stock.

Last quarter Aflac reported $5 billion in Revenue and $1.56 earnings per share. This beat revenue expectation by $1 billion and missed earnings estimates by -$.06.

In the last 3 years, AFL traded as high as $115.50 and as low as $52.07.

The top ETF exchange traded funds that AFL belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.

AFL has outperformed the market in the last year with a price return of +19.2% while the SPY ETF lost -2.9%. AFL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning -2.4% and -9.0%, respectively, while the SPY returned -15.4% and -13.5%, respectively.

AFL support price is $98.48 and resistance is $101.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AFL shares will trade within this expected range on the day.